Signaling and immunoresolving actions of resolvin d1 in inflamed human visceral adipose tissue

Journal of Immunology

Volumn 197, Issue 8, 2016, Pages 3360-3370

  Titos, Esther ^a,b   Rius, Bibiana ^a   López Vicario, Cristina ^a   Alcaraz Quiles, Jose ^a   Garća Alonso, Veronica ^a   Lopategi, Aritz ^a   Dalli, Jesmond ^c   Lozano, Juan Jose ^b   Arroyo, Vicente ^d   Delgado, Salvadora ^a   Serhan, Charles N ^c   Clària, Joan ^a,b,e  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d European Foundation for the Study of Chronic Liver Failure EF Clif   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; LIPOXIN; MITOGEN ACTIVATED PROTEIN KINASE P38; RESOLVIN D1; STAT1 PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; DOCOSAHEXAENOIC ACID;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAPERITONEAL FAT; MACROPHAGE; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CELL CULTURE; CHEMISTRY; IMMUNOLOGY; INFLAMMATION; INTRAABDOMINAL FAT; PATHOLOGY;

CELLS, CULTURED; DOCOSAHEXAENOIC ACIDS; HUMANS; INFLAMMATION; INTRA-ABDOMINAL FAT; OBESITY; SIGNAL TRANSDUCTION;

EID: 84991448148     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502522     Document Type: Article

References (34)

1. Ferrante Jr., A. W., 2007. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Intern. Med. 262: 408-414.
2. Hotamisligil, G. S. 2006. Inflammation and metabolic disorders. Nature 444: 860-867.
3. Ouchi, N., J. L. Parker, J. J. Lugus, and K. Walsh. 2011. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11: 85-97.
4. Chawla, A., K. D. Nguyen, and Y. P. Goh. 2011. Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 11: 738-749.
5. Spite, M., J. Clària, and C. N. Serhan. 2014. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 19: 21-36.
6. Gilroy, D. W., T. Lawrence, M. Perretti, and A. G. Rossi. 2004. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3: 401-416.
7. Serhan, C. N. 2014. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510: 92-101.
8. Hellmann, J., Y. Tang, M. Kosuri, A. Bhatnagar, and M. Spite. 2011. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 25: 2399-2407.
9. González-Périz, A., R. Horrillo, N. Ferré, K. Gronert, B. Dong, E. Morán-Salvador, E. Titos, M. Martńez-Clemente, M. López-Parra, et al. 2009. Obesityinduced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 23: 1946-1957.
10. Titos, E., B. Rius, A. González-Périz, C. López-Vicario, E. Morán-Salvador, M. Martńez-Clemente, V. Arroyo, and J. Clària. 2011. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J. Immunol. 187: 5408-5418.
11. Clària, J., J. Dalli, S. Yacoubian, F. Gao, and C. N. Serhan. 2012. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J. Immunol. 189: 2597-2605.
12. Rius, B., E. Titos, E. Morán-Salvador, C. López-Vicario, V. Garća-Alonso, A. González-Périz, V. Arroyo, and J. Clària. 2014. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. FASEB J. 28: 836-848.
13. Schif-Zuck, S., N. Gross, S. Assi, R. Rostoker, C. N. Serhan, and A. Ariel. 2011. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur. J. Immunol. 41: 366-379.
14. Serhan, C. N., and J. Savill. 2005. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6: 1191-1197.
15. Schwab, J. M., N. Chiang, M. Arita, and C. N. Serhan. 2007. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447: 869-874.
16. Wiejak, J., J. Dunlop, S. P. Mackay, and S. J. Yarwood. 2013. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells. Biochem. J. 454: 283-293.
17. Ritchie, M. E., B. Phipson, D. Wu, Y. Hu, C. W. Law, W. Shi, and G. K. Smyth. 2015. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43: e47.
18. Colas, R. A., M. Shinohara, J. Dalli, N. Chiang, and C. N. Serhan. 2014. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am. J. Physiol. Cell Physiol. 307: C39-C54.
19. Abraham, N. G., and G. Drummond. 2006. CD163-Mediated hemoglobin-heme uptake activates macrophage HO-1, providing an antiinflammatory function. Circ. Res. 99: 911-914.
20. El Kasmi, K. C., J. Holst, M. Coffre, L. Mielke, A. de Pauw, N. Lhocine, A. M. Smith, R. Rutschman, D. Kaushal, Y. Shen, et al. 2006. General nature of the STAT3-activated anti-inflammatory response. J. Immunol. 177: 7880-7888.
21. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7: 454-465.
22. Radtke, S., S. Wuller, X. P. Yang, B. E. Lippok, B. Mutze, C. Mais, H. S. de Leur, J. G. Bode, M. Gaestel, P. C. Heinrich, et al. 2010. Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation. J. Cell Sci. 123: 947-959.
23. Mori, T., T. Miyamoto, H. Yoshida, M. Asakawa, M. Kawasumi, T. Kobayashi, H. Morioka, K. Chiba, Y. Toyama, and A. Yoshimura. 2011. IL-1b and TNFainitiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. Int. Immunol. 23: 701-712.
24. Pike, K. A., A. P. Hutchins, V. Vinette, J. F. Théberge, L. Sabbagh, M. L. Tremblay, and D. Miranda-Saavedra. 2014. Protein tyrosine phosphatase 1B is a regulator of the interleukin-10-induced transcriptional program in macrophages. Sci. Signal. 7: ra43.
25. O'Farrell, A. M., Y. Liu, K. W. Moore, and A. L. Mui. 1998. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and-independent pathways. EMBO J. 17: 1006-1018.
26. Lee, T. S., and L. Y. Chau. 2002. Heme oxygenase-1 mediates the antiinflammatory effect of interleukin-10 in mice. Nat. Med. 8: 240-246.
27. Arend, W. P., M. Malyak, C. J. Guthridge, and C. Gabay. 1998. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16: 27-55.
28. Clària, J., B. T. Nguyen, A. L. Madenci, C. K. Ozaki, and C. N. Serhan. 2013. Diversity of lipid mediators in human adipose tissue depots. Am. J. Physiol. Cell Physiol. 304: C1141-C1149.
29. Wajchenberg, B. L., D. Giannella-Neto, M. E. da Silva, and R. F. Santos. 2002. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm. Metab. Res. 34: 616-621.
30. Schindler, C., D. E. Levy, and T. Decker. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282: 20059-20063.
31. Villarino, A. V., Y. Kanno, J. R. Ferdinand, and J. J. O'Shea. 2015. Mechanisms of Jak/STAT signaling in immunity and disease. J. Immunol. 194: 21-27.
32. Ashwell, J. D. 2006. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat. Rev. Immunol. 6: 532-540.
33. Cooray, S. N., T. Gobbetti, T. Montero-Melendez, S. McArthur, D. Thompson, A. J. Clark, R. J. Flower, and M. Perretti. 2013. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc. Natl. Acad. Sci. USA 110: 18232-18237.
34. Croasdell, A., T. H. Thatcher, R. M. Kottmann, R. A. Colas, J. Dalli, C. N. Serhan, P. J. Sime, and R. P. Phipps. 2015. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 309: L888-L901.